These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 29795359)

  • 1. Identification of small molecule inhibitors targeting the SMARCA2 bromodomain from a high-throughput screening assay.
    Lu T; Hu JC; Lu WC; Han J; Ding H; Jiang H; Zhang YY; Yue LY; Chen SJ; Jiang HL; Chen KX; Chai HF; Luo C
    Acta Pharmacol Sin; 2018 Sep; 39(9):1544-1552. PubMed ID: 29795359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of novel CBP bromodomain inhibitors through TR-FRET-based high-throughput screening.
    Zhang FC; Sun ZY; Liao LP; Zuo Y; Zhang D; Wang J; Chen YT; Xiao SH; Jiang H; Lu T; Xu P; Yue LY; Du DH; Zhang H; Liu CP; Luo C
    Acta Pharmacol Sin; 2020 Feb; 41(2):286-292. PubMed ID: 31253937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The SMARCA2/4 ATPase Domain Surpasses the Bromodomain as a Drug Target in SWI/SNF-Mutant Cancers: Insights from cDNA Rescue and PFI-3 Inhibitor Studies.
    Vangamudi B; Paul TA; Shah PK; Kost-Alimova M; Nottebaum L; Shi X; Zhan Y; Leo E; Mahadeshwar HS; Protopopov A; Futreal A; Tieu TN; Peoples M; Heffernan TP; Marszalek JR; Toniatti C; Petrocchi A; Verhelle D; Owen DR; Draetta G; Jones P; Palmer WS; Sharma S; Andersen JN
    Cancer Res; 2015 Sep; 75(18):3865-3878. PubMed ID: 26139243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unravelling novel congeners from acetyllysine mimicking ligand targeting a lysine acetyltransferase PCAF bromodomain.
    Suryanarayanan V; Singh SK
    J Biomol Struct Dyn; 2018 Dec; 36(16):4303-4319. PubMed ID: 29228881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bromodomain biology and drug discovery.
    Zaware N; Zhou MM
    Nat Struct Mol Biol; 2019 Oct; 26(10):870-879. PubMed ID: 31582847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Research progress of selective small molecule bromodomain-containing protein 9 inhibitors.
    Hui M; Jian Z; Peiyuan Z; Zhenwei W; Huibin Z
    Future Med Chem; 2018 Apr; 10(8):895-906. PubMed ID: 29620420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of novel BRD4 inhibitors by high-throughput screening, crystallography, and cell-based assays.
    Sun Z; Zhang H; Chen Z; Xie Y; Jiang H; Chen L; Ding H; Zhang Y; Jiang H; Zheng M; Luo C
    Bioorg Med Chem Lett; 2017 May; 27(9):2003-2009. PubMed ID: 28347667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of BRD4 bromodomain inhibitors by fragment-based high-throughput docking.
    Zhao H; Gartenmann L; Dong J; Spiliotopoulos D; Caflisch A
    Bioorg Med Chem Lett; 2014 Jun; 24(11):2493-6. PubMed ID: 24767840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-throughput strategy to identify inhibitors of histone-binding domains.
    Wagner EK; Albaugh BN; Denu JM
    Methods Enzymol; 2012; 512():161-85. PubMed ID: 22910207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of I-BRD9, a Selective Cell Active Chemical Probe for Bromodomain Containing Protein 9 Inhibition.
    Theodoulou NH; Bamborough P; Bannister AJ; Becher I; Bit RA; Che KH; Chung CW; Dittmann A; Drewes G; Drewry DH; Gordon L; Grandi P; Leveridge M; Lindon M; Michon AM; Molnar J; Robson SC; Tomkinson NC; Kouzarides T; Prinjha RK; Humphreys PG
    J Med Chem; 2016 Feb; 59(4):1425-39. PubMed ID: 25856009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NMR-based platform for fragment-based lead discovery used in screening BRD4-targeted compounds.
    Yu JL; Chen TT; Zhou C; Lian FL; Tang XL; Wen Y; Shen JK; Xu YC; Xiong B; Zhang NX
    Acta Pharmacol Sin; 2016 Jul; 37(7):984-93. PubMed ID: 27238211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pan-SMARCA/PB1 Bromodomain Inhibitors and Their Role in Regulating Adipogenesis.
    Wanior M; Preuss F; Ni X; Krämer A; Mathea S; Göbel T; Heidenreich D; Simonyi S; Kahnt AS; Joerger AC; Knapp S
    J Med Chem; 2020 Dec; 63(23):14680-14699. PubMed ID: 33216538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of novel cellular histone-binding and chromatin-displacement assays for bromodomain drug discovery.
    Zhan Y; Kost-Alimova M; Shi X; Leo E; Bardenhagen JP; Shepard HE; Appikonda S; Vangamudi B; Zhao S; Tieu TN; Jiang S; Heffernan TP; Marszalek JR; Toniatti C; Draetta G; Tyler J; Barton M; Jones P; Palmer WS; Geck Do MK; Andersen JN
    Epigenetics Chromatin; 2015; 8():37. PubMed ID: 26396593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The identification of novel small-molecule inhibitors targeting WDR5-MLL1 interaction through fluorescence polarization based high-throughput screening.
    Ye X; Zhang R; Lian F; Zhang W; Lu W; Han J; Zhang N; Jin J; Luo C; Chen K; Ye F; Ding H
    Bioorg Med Chem Lett; 2019 Feb; 29(4):638-645. PubMed ID: 30626558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery and Optimization of a Selective Ligand for the Switch/Sucrose Nonfermenting-Related Bromodomains of Polybromo Protein-1 by the Use of Virtual Screening and Hydration Analysis.
    Myrianthopoulos V; Gaboriaud-Kolar N; Tallant C; Hall ML; Grigoriou S; Brownlee PM; Fedorov O; Rogers C; Heidenreich D; Wanior M; Drosos N; Mexia N; Savitsky P; Bagratuni T; Kastritis E; Terpos E; Filippakopoulos P; Müller S; Skaltsounis AL; Downs JA; Knapp S; Mikros E
    J Med Chem; 2016 Oct; 59(19):8787-8803. PubMed ID: 27617704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-throughput screening with nucleosome substrate identifies small-molecule inhibitors of the human histone lysine methyltransferase NSD2.
    Coussens NP; Kales SC; Henderson MJ; Lee OW; Horiuchi KY; Wang Y; Chen Q; Kuznetsova E; Wu J; Chakka S; Cheff DM; Cheng KC; Shinn P; Brimacombe KR; Shen M; Simeonov A; Lal-Nag M; Ma H; Jadhav A; Hall MD
    J Biol Chem; 2018 Aug; 293(35):13750-13765. PubMed ID: 29945974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural ramification for acetyl-lysine recognition by the bromodomain of human BRG1 protein, a central ATPase of the SWI/SNF remodeling complex.
    Singh M; Popowicz GM; Krajewski M; Holak TA
    Chembiochem; 2007 Jul; 8(11):1308-16. PubMed ID: 17582821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Overview on Small Molecule Inhibitors of BRD4.
    Huang W; Zheng X; Yang Y; Wang X; Shen Z
    Mini Rev Med Chem; 2016; 16(17):1403-1414. PubMed ID: 27290915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of a highly potent CECR2 bromodomain inhibitor with 7H-pyrrolo[2,3-d] pyrimidine scaffold.
    Lu H; Lu T; Zu S; Duan Z; Guang Y; Li Q; Ma J; Chen D; Li B; Lu W; Jiang H; Luo C; Ye D; Chen K; Lin H
    Bioorg Chem; 2022 Jun; 123():105768. PubMed ID: 35378372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of 1,8-acridinedione derivatives as novel GCN5 inhibitors via high throughput screening.
    Xiong H; Han J; Wang J; Lu W; Wang C; Chen Y; Fulin Lian ; Zhang N; Liu YC; Zhang C; Ding H; Jiang H; Lu W; Luo C; Zhou B
    Eur J Med Chem; 2018 May; 151():740-751. PubMed ID: 29665527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.